Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Comparison of Ketamine Combine Propofol vs Propofol Anesthesia in Schizophrenia Electroconvulsive Therapy [Phase 4]
Phase 4 clinical trial update comparing ketamine-Propofol combination anesthesia to Propofol alone in schizophrenia patients undergoing elec…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating the impact of Risperdal Consta on the benefit of social skills training in patients with schizophrenia or …
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia [Phase 1, Phase 2]
A completed clinical trial evaluating curcumin for cognitive dysfunction in schizophrenia (Phase 1/Phase 2) with published results.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Schizophrenia TreAtment With electRic Transcranial Stimulation [Phase 3]
Phase 3 clinical trial update for schizophrenia treatment using electroconvulsive stimulation (electRic Transcranial Stimulation) completed.
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Development of a Mobile System for Self-management of Schizophrenia (SOS) [NA]
A completed clinical trial evaluating a mobile self-management system for schizophrenia and schizoaffective disorder; results posted in 2019…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia [Phase 4]
Phase 4 trial assessing the effect of N-acetylcysteine on cortical erosion in early-stage schizophrenia; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Nicotinic Receptors and Schizophrenia [Phase 2]
Phase 2 clinical trial update on nicotinic receptor-targeted approach for schizophrenia and schizoaffective disorder; results posted after c…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial investigating add-on ramelteon for sleep and circadian rhythm disruption in schizophrenia has completed.
-
CLINICAL_TRIALS withdrawal · 2019-04-24Clinical Trial Update: Alleviating the Metabolic Side Effects of Antipsychotic Medications [Phase 4]
A Phase 4 clinical trial investigating methods to alleviate metabolic side effects of antipsychotic medications has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Study to Demonstrate Cognitive Enhancing Effects of BF2.649 [Phase 2]
A Phase 2 trial evaluating the cognitive enhancing effects of BF2.649 in schizophrenia has completed, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: rTMS Treatment for Positive and Negative Symptoms of Schizophrenia [Phase 2, Phase 3]
Clinical trial update on repetitive transcranial magnetic stimulation (rTMS) for positive and negative symptoms of schizophrenia, reported a…
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms [Phase 2]
Phase 2 trial update investigating minocycline for negative symptoms in schizophrenia, including extent and potential mechanisms.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy [Phase 4]
Phase 4 trial comparing the combination of olanzapine and amisulpride to monotherapy in schizophrenia and schizoaffective disorder has compl…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating ketamine's effect on cortical electrophysiological activity linked to the semantic affective dimension o…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Fingolimod in Schizophrenia Patients [Phase 2]
Phase 2 trial update of fingolimod in schizophrenia has completed with results posted.
-
FDA approval · 2019-04-11FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients [Phase 4]
Phase 4 clinical trial evaluating paliperidone ER (Invega) for depressive symptoms in schizophrenia patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects [Phase 1]
Phase 1 pharmacokinetic study of lurasidone after multiple oral administrations in healthy subjects; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia [NA]
This completed clinical trial evaluated nicotinic enhancement of cognitive remediation training in schizophrenia and schizoaffective disorde…
-
FDA approval · 2019-04-05FDA Approved: THIOTHIXENE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original application for thiothixene, a thioxanthene antipsychotic, for the treatment of schizophrenia…
-
FDA approval · 2019-04-04FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from Somerset Therapeutics, LLC, related to the long-acting antipsychotic …
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: A Clinical Trial of Lurasidone in Treatment of Schizophrenia [Phase 3]
Phase 3 clinical trial update for lurasidone in schizophrenia has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders [Phase 2]
Phase 2 trial evaluating pentosan polysulfate sodium and meclofenamic acid for psychotic disorders, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates [Phase 4]
Phase 4 trial evaluating varenicline for smoking cessation in schizophrenia with antipsychotic-induced neurological symptoms as correlates; …
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Behavior During Experimentally Induced Pain [NA]
Completed clinical trial investigating behavior during experimentally induced pain in individuals with schizophrenia and major depression; r…